Clinical Minds

Go behind the scenes of clinical research with some of the leading minds in life sciences. Discover what’s happening in today’s world of clinical trials, the technology and ideas transforming them, and why it matters for each and every one of us. This is Clinical Minds, presented by Medidata.

Science
Life Sciences
1
Adopting Clinical Trial Technology: The Key to ...
24 min
2
Clinical Trial Patient Recruitment: One Size Do...
39 min
3
The Power of Patient Insights: Solutions Design...
17 min
4
Give Me My Data: How Patient Access Builds Trus...
24 min
5
How the FDA is focused on improving clinical tr...
<p>The U.S. population is growing increasingly diverse and ensuring that we have meaningful representation of racial and ethnic minorities and other diverse populations in clinical trials for regulated medical products is fundamental not only to FDA's regulatory mission, but also public health,” Dr. Jovonni Spinner, Associate Director of Outreach and Communications at the FDA's Office of Minority Health and Health Equity.</p> <p><br></p> <p>Related links</p> <p><a href="https://www.fda.gov/about-fda/office-commissioner/office-minority-health-and-health-equity"><u>https://www.fda.gov/about-fda/office-commissioner/office-minority-health-and-health-equity</u></a></p> <p><a href="https://www.beaconpublichealth.com/"><u>https://www.beaconpublichealth.com/</u></a></p>
28 min
6
How to better bridge the gaps in Latinx patient...
<p>The simplest thing to do is to find out what kind of patients you have. Find out what cultures they are. Learn about the culture. Learn to connect. Be a human. Don't just be a robot that does science. Don't speak above someone's level. Speak to them. Put yourself in that patient's shoes, and speak to them kindly,” says Dr. Fabian Sandoval, CEO and Research Director of the Emerson Clinical Research Institute in Washington, DC, and Emmy winner and host of the weekly medical TV show "Tu Salud, Tu Familia</p>
17 min
7
The importance of community building, patient t...
<p>Currently our black and brown communities are really grossly underrepresented in cancer clinical trials, and we need to fix that. Historical barriers around egregious medical behaviors that have taken place in the past, cultural barriers, language barriers, and finally socioeconomic barriers impact the outcome of someone’s cancer journey,” says Dana Dornsife, founder and CEO at Lazarex Cancer Foundation, a nationwide non-profit org she founded in 2006.</p>
24 min
8
A brief history of inequity in the practice of ...
<p>A lot has to do with the ability to admit the painful truth about American racism in healthcare and then to make the equally painful changes that it requires,” says Harriet A. Washington, medical ethicist, American writer, and the author of Medical Apartheid: The Dark History of Medical Experimentation on Black Americans from Colonial Times to the Present and Carte Blanche</p>
25 min
9
Introducing Season 2: Diversity in Clinical Trials
<p>Introducing Season 2 of Clinical Minds! An entire season dedicated to why diversity in clinical trials is so important and what’s being done to improve participation among underrepresented populations.</p> <p>To kick things off, host Paul Oestreicher chats with Jackie Kent, evp and chief customer officer at Medidata, a Dassault Systèmes</p>
1 min
10
What is a patient equation?
<p>Glen de Vries, co-founder and co CEO of Medidata and author of the upcoming book, <em>The Patient Equation: The Precision Medicine Revolution in the Age of COVID-19 and Beyond </em>on how to bring together everything learned about COVID-19 to find treatments and vaccines and what can be done to make sure something like this doesn't happen again.</p>
11 min
11
What if a treatment already exists?
<p>Dr. David Fajgenbaum, physician, scientist and author of the bestselling memoir, <em>Chasing My Cure: A Doctor's Race to Turn Hope Into Action</em>, on his approach to drug repurposing, how he and a team of volunteers have been applying this approach to Covid-19, and why this gives hope for all diseases with unmet need.</p>
14 min
12
What is the data telling us?
<p>Fareed Melhem, head of Acorn AI Labs, on what data trends reveal about Covid-19's global impact on clinical research, and how data science is being used to overcome challenges created by the pandemic.</p>
11 min
13
What do virtual clinical trials look like?
<p>Anthony Costello, senior vice president of mobile health at Medidata, on what clinical trials look like when people are unable or unwilling to leave home, what this means for the race for a vaccine, and how mobile health technology is paving the way.</p>
12 min
14
How do we keep clinical trial patients safe in ...
<p>How&nbsp;drugs&nbsp;go&nbsp;from a&nbsp;lab, to&nbsp;testing&nbsp;in&nbsp;humans, to&nbsp;your&nbsp;local&nbsp;pharmacy.&nbsp;Here's&nbsp;what’s&nbsp;happening&nbsp;in the&nbsp;world&nbsp;of&nbsp;clinical&nbsp;research&nbsp;today, the&nbsp;technology&nbsp;and&nbsp;ideas&nbsp;that are&nbsp;transforming&nbsp;it, and why this&nbsp;matters&nbsp;for&nbsp;patients. Which is&nbsp;all&nbsp;of&nbsp;us.&nbsp;<a href="http://www.medidata.com/" target="_blank">Presented by Medidata</a>.</p>
8 min
15
When will we get the vaccine?
<p>Clinical&nbsp;trials 101. Alicia Staley, director of patient engagement at Medidata, on why it takes so long to develop&nbsp;drugs&nbsp;and vaccines, what&nbsp;clinical&nbsp;trials are, and how&nbsp;clinical&nbsp;trials can do better for&nbsp;patients.</p>
13 min